UK government

Downing Street, London, UK
#Association of the British Pharmaceutical Industry #Pharmaceutical industry #UK #UK government

Changes to UK Statutory Scheme go ahead despite pharma criticism

The UK government has published new terms for the Statutory Scheme for branded medicines, which controls the prices of medicines paid by the NHS. The announcement follows the agreement in mid-November of a new Voluntary Scheme for Pricing, Access and Growth (VPAG), a negotiated alternative scheme which companies can opt… Read More

#Business & Investment #News #Trending News

#ABPI #Association of the British Pharmaceutical Industry #Pharmaceutical industry #UK #UK government

Industry rejects ‘damaging’ changes to UK medicines scheme

Over twenty pharma companies have rejected the UK government’s proposed changes to the statutory scheme for branded medicines, the latest move in an ongoing disagreement between the government and industry. According to the Association of the British Pharmaceutical industry (ABPI), the “radical plans” are “unworkable”. And… Read More

#News

EU flag
#ABPI #Cancer Research UK #EU #Horizon Europe #Life sciences #UK government

UK joins Horizon Europe in “huge win” for research community

Following lengthy negotiations, the UK government has announced that the UK will be participating as a fully associated member of Horizon Europe for the remaining life of the programme to 2027. UK researchers can now apply for grants and bid to take part in projects under… Read More

#News #Trending News

EU flag
#Brexit #Europe #Funding #Horizon Europe #Life sciences #UK government

Horizon Europe delay damaging UK’s reputation as a science leader

As negotiations continue between the UK and EU over Horizon Europe, the largest collaborative research programme in the world, the scientific research community has urged the Prime Minister to secure the UK’s membership as soon as possible.  Figures reported in The Guardian from the European… Read More

#News #Trending News

Downing Street, London, UK
#ABPI #Antibiotic resistance #Antimicrobial resistance (AMR) #UK government

UK announces £210 million fund to tackle antimicrobial resistance

The UK government has announced up to £210 ($267) million of funding to partner with countries across Asia and Africa to tackle antimicrobial resistance (AMR) and reduce the threat posed to the UK. The announcement follows the £39 ($48) million investment through the Global… Read More

#News

UK financial markets
#ABPI #Investment #Life sciences #UK #UK government

International investors abandon UK life sciences

International investors are abandoning UK life sciences as excessive revenue clawback rates start to bite, according to the latest Life Sciences Competitiveness Indicators published by the government1. The UK saw a substantial drop in the estimated value of inward life sciences foreign direct investment (FDI) in 2022 compared to 2021,… Read More

#Business & Investment #Editor's Choice #News

Antibiotics
#ABPI #Antibiotics #Antimicrobial resistance (AMR) #Investment #UK government

UK government invests £39 million in AMR research

The UK government will invest up to £39 ($48) million in antimicrobial resistance (AMR) research through the Global AMR Innovation Fund (GAMRIF). The funding includes up to £25 ($30.9) million awarded to support the early development of new antibiotics, vaccines, rapid diagnostics and other products to… Read More

#Editor's Choice #News

Chancellor Jeremy Hunt and the Spring Budget
#Association of the British Pharmaceutical Industry #BioIndustry Association #Investment #Life sciences #MHRA #Regulatory #UK #UK budget #UK government

UK Spring Budget a ‘vote of confidence’ in UK life sciences

There was some good news for the UK life sciences sector in the government’s Spring Budget, but did it go far enough? DDW’s Diana Spencer takes a look at the industry’s reaction. There wasn’t much to write home about in the UK government’s Spring Budget, described by Bloomberg UK’s Marcus… Read More

#Business & Investment #Exclusive Content

Downing Street, London, UK
#BioIndustry Association #Biotechnology #Research & development #UK budget #UK government

Industry calls on UK Government to support biotech SMEs

Ahead of the UK’s Spring Budget, the UK BioIndustry Association (BIA) is calling on the Treasury to provide additional support through the R&D tax relief scheme to R&D intensive SMEs. These companies are the most at risk from the R&D tax relief rate cut announced at… Read More

#News

The Backstop solution for the Irish border
#Association of the British Pharmaceutical Industry #European Commission #Northern Ireland #Pharmaceutical industry #UK government

Windsor Framework addresses drug supply issues in NI

The European Commission and the UK Government have reached a political agreement that they hope will address the challenges faced by citizens and businesses in Northern Ireland (NI) following Brexit. The Windsor Framework, which focuses on a variety of issues, including supply of medicines, constitutes a comprehensive set of joint… Read More

#News #Trending News

#AbbVie #ABPI #Clinical trials #Eli Lilly #Life sciences #Pharmaceutical industry #Pharmaceuticals #UK #UK government

Pharma firms pull out of UK drug pricing agreement

AbbVie and Eli Lilly have left the voluntary medicines pricing agreement in protest over what they describe as “increasingly punitive revenue clawbacks”.  The companies have left the UK’s Voluntary Scheme for Branded Medicines Pricing and Access (VPAS), a long-standing agreement between government and industry with roots going back to the… Read More

#Business & Investment #News #Trending News

Vaccine production
#BioNTech #Cancer immunotherapy #Cancer research #Clinical trials #Immunotherapy #Moderna #mRNA #mRNA-based vaccines #Personalised medicine #UK government

New UK partnership to accelerate mRNA research

It is hoped that a new partnership between the UK government and BioNTech will help accelerate clinical trials of personalised immunotherapies for cancer and infectious disease vaccines.  The agreement means cancer patients will get early access to trials exploring personalised mRNA therapies, like cancer vaccines.  Professor Uğur Şahin, Chief Executive… Read More

#Business & Investment #Cancer Research #News #Trending News

Big Ben and Houses of Parliament
#Cancer research #Drug discovery #Funding #Mental health #UK government

Cancer research to get £22.5 million share of UK fund

The UK government has promised that patients will benefit from cutting-edge new treatments with the introduction of a Vaccine Taskforce style approach to tackling health challenges.  The government has committed over £113 ($135) million to fund research into four healthcare missions – cancer, obesity, mental health and addiction. Building… Read More

#Cancer Research #News

Rishi Sunak presenting the UK budget
#Academy of Medical Sciences #BioIndustry Association #Biomedical research #Cancer Research UK #Economy #Funding #Investment #UK budget #UK economy #UK government

UK biomedical organisations warn against research cuts 

Ahead of the UK Government’s Autumn Statement on Thursday, leading biomedical research companies, charities and institutions have called for the Chancellor to place medical and health research at the heart of plans for growth.  The letter has been signed by the Academy of Medical Sciences, Pfizer, Wellcome,… Read More

#News